Skip to content

Welcome to Discover Pharma! Today is : October 18, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

News

NewsDebbie2026-02-23T12:06:10+00:00
  • All
  • Advanced Therapies
  • Biotech & Pharma Business
  • Central Nervous System
  • Clinical & Regulatory
  • Digital & Data
  • Drug Delivery & Formulation
  • Drug Discovery & Development
  • Genomics and sequencing
  • Manufacturing & Supply Chain
  • Medical devices
  • Opinion & Events
  • Pharmaceuticals and therapeutics
  • Research & Development
  • Therapeutic Areas
  • Uncategorised
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development

    ViiV Healthcare HIV regimen Dovato non-inferior to Biktarvy in Phase 3b study

    read more
  • Clinical & Regulatory,Medical devices,Pharmaceuticals and therapeutics,Research & Development

    Seegene data finds STI pathogens in 82% of HPV-positive test results

    read more
  • Digital & Data,Drug Delivery & Formulation,Research & Development

    AI-driven antibody discovery could create $7bn market for life science tools

    read more
  • Clinical & Regulatory,Manufacturing & Supply Chain

    Pace Life Sciences passes FDA inspection at North Carolina facility

    read more
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    CAMP4 wins Australian clearance to begin Phase 1/2 trial of SYNGAP1 therapy

    read more
  • Genomics and sequencing,Research & Development

    Novogene expands single-cell sequencing capability in Cambridge

    read more
  • Manufacturing & Supply Chain,Medical devices,Research & Development

    Femtosecond lasers could offer alternative to PFAS coatings

    read more
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    CHMP recommends EU marketing authorisation for two obicetrapib treatments

    read more
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    CHMP recommends EU approval of Lynavoy for cholestatic pruritus in PBC

    read more
  • Central Nervous System,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development

    CHMP recommends approval of NEZGLYAL for rare neurodegenerative disease

    read more
  • Medical devices,Research & Development

    Aravind and Alcon launch global retina surgery training centre in India

    read more
  • Advanced Therapies,Clinical & Regulatory,Genomics and sequencing,Pharmaceuticals and therapeutics,Research & Development

    Atsena receives EMA orphan designation for two inherited retinal disease gene therapies

    read more
  • Clinical & Regulatory,Medical devices,Pharmaceuticals and therapeutics,Research & Development

    IOTA founder recognised for global impact on ovarian tumour diagnosis

    read more
  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain,Medical devices,Research & Development

    Pioneer launches regional accelerator programmes for life science and tech start-ups

    read more
  • Clinical & Regulatory,Medical devices,Opinion & Events,Research & Development

    Fetal medicine pioneer recognised for expanding access to ultrasound education

    read more
  • Biotech & Pharma Business,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Opella invests $70m in Mexico to expand Enterogermina production

    read more
Previous111213Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • NVision deploys quantum-enhanced MRI platform at Hokkaido University
    Categories: Digital & Data, Drug Discovery & Development, Research & Development
  • L-glutamine shows 44% response rate in Phase 1 pancreatic cancer trial
    Categories: Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Systech launches AI-assisted pharmaceutical traceability platform
    Categories: Digital & Data, Manufacturing & Supply Chain
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top